A temporally resolved CRISPR-Cas9 screen reveals DAC-induced DNA damage drives trans-cell cycle cytotoxicity that depends on ...
CRISPR technology has radically transformed genetic research, and at the forefront of this transformation is CRISPR screening ...
Ongoing launch of CASGEVY ® continues to gain momentum; new cell patient collection initiations expected to significantly grow in 2025- -More than 50 authorized treatment centers (ATCs) activated ...
Northwestern Medicine investigators have developed a new avenue to reprogram compromised immune cells to act against tumors, ...
Gene therapies to treat rheumatoid arthritis have evolved slowly, but one is ready to move into human trials and an ...
Beans are a key food at the dietary level, boasting high nutritional value and constituting the most directly consumed legume ...
Ongoing launch of CASGEVY® continues to gain momentum; new cell patient collection initiations expected to significantly ...
Bristol Myers Squibb's FDA nod for Breyanzi (liso-cel) in relapsed/refractory CLL/SLL boosts its CAR T-cell portfolio, ...
5d
AZoLifeSciences on MSNNew CRISPR Tool Reveals Key Lymphoma GenesThis study presents an optimized CRISPR-Cas12a system for large-scale genetic screening, revealing critical genes involved in ...
In a landmark achievement for both Uganda and the global medical community, the United States Patent and Trademark Office ...
Biomedical engineers at Duke University have demonstrated a promising new approach that could be used to treat a rare and complex class of genetic ...
New gene therapy modalities, such as CRISPR guide RNA (single guide ribonucleic acid [sgRNA]) and messenger RNA (mRNA), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results